Name:
Sodium permanganate monohydrate 97%
Synonym:
Permanganic acid, sodium salt, hydrate; Sodium permanganate hydrate
CAS:
0-00-1
Section 1 - Chemical Product
MSDS Name:Sodium permanganate monohydrate 97%
Synonym:Permanganic acid, sodium salt, hydrate; Sodium permanganate hydrate
Synonym:Permanganic acid, sodium salt, hydrate; Sodium permanganate hydrate
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 0-00-1 |
| Hazard Symbols: O Risk Phrases: |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Contact with combustible material may cause fire.
Potential Health Effects
Eye:
May cause conjunctivitis. Causes severe eye irritation and possible injury. May cause permanent corneal opacification.
Skin:
May cause severe irritation and possible burns.
Ingestion:
May cause perforation of the digestive tract. May cause burns to the gastrointestinal tract.
Inhalation:
May cause severe respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Extreme exposures could result in a build-up of fluid in the lungs (pulmonary edema) that might be fatal in severe cases.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Contact with combustible material may cause fire.
Potential Health Effects
Eye:
May cause conjunctivitis. Causes severe eye irritation and possible injury. May cause permanent corneal opacification.
Skin:
May cause severe irritation and possible burns.
Ingestion:
May cause perforation of the digestive tract. May cause burns to the gastrointestinal tract.
Inhalation:
May cause severe respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Extreme exposures could result in a build-up of fluid in the lungs (pulmonary edema) that might be fatal in severe cases.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Do not use mouth-to-mouth resuscitation if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device.
Notes to Physician:
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Do not use mouth-to-mouth resuscitation if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device.
Notes to Physician:
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Strong oxidizer. Contact with other material may cause fire. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Use water with caution and in flooding amounts. May accelerate burning if involved in a fire.
Containers may explode when heated. Runoff to sewer may create fire or explosion hazard.
Extinguishing Media:
Use water only! Do NOT use carbon dioxide or dry chemical. Do NOT use alcohol foams.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Strong oxidizer. Contact with other material may cause fire. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Use water with caution and in flooding amounts. May accelerate burning if involved in a fire.
Containers may explode when heated. Runoff to sewer may create fire or explosion hazard.
Extinguishing Media:
Use water only! Do NOT use carbon dioxide or dry chemical. Do NOT use alcohol foams.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal.
Remove all sources of ignition. Provide ventilation. Keep combustibles (wood, paper, oil, etc.,) away from spilled material.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal.
Remove all sources of ignition. Provide ventilation. Keep combustibles (wood, paper, oil, etc.,) away from spilled material.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Do not get in eyes, on skin, or on clothing. Avoid contact with clothing and other combustible materials. Do not ingest or inhale. Use only in a chemical fume hood.
Storage:
Do not store near combustible materials. Keep containers tightly closed. Store in a cool, dry area away from incompatible substances.
Avoid storage on wood floors.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Do not get in eyes, on skin, or on clothing. Avoid contact with clothing and other combustible materials. Do not ingest or inhale. Use only in a chemical fume hood.
Storage:
Do not store near combustible materials. Keep containers tightly closed. Store in a cool, dry area away from incompatible substances.
Avoid storage on wood floors.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 0-00-1: CAS# 10101-50-5: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 0-00-1: CAS# 10101-50-5: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Crystalline powder
Color: dark red-black
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 170 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 170 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 2.47
Molecular Formula: MnNaO4.H2O
Molecular Weight: 159.94
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Ignition sources, dust generation.
Incompatibilities with Other Materials:
Strong reducing agents, strong acids, acetic acid, acetic anhydride, ammonia, finely powdered metals, phosphorus, sulfur, ammonium salts, organic materials.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, sodium oxide.
Hazardous Polymerization: Has not been reported
Stable under normal temperatures and pressures.
Conditions to Avoid:
Ignition sources, dust generation.
Incompatibilities with Other Materials:
Strong reducing agents, strong acids, acetic acid, acetic anhydride, ammonia, finely powdered metals, phosphorus, sulfur, ammonium salts, organic materials.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, sodium oxide.
Hazardous Polymerization: Has not been reported
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 0-00-1 unlisted.
CAS# 10101-50-5: SD6650000 LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Sodium permanganate monohydrate - Not listed by ACGIH, IARC, or NTP.
Sodium permanganate anhydrous - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 0-00-1 unlisted.
CAS# 10101-50-5: SD6650000 LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Sodium permanganate monohydrate - Not listed by ACGIH, IARC, or NTP.
Sodium permanganate anhydrous - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: SODIUM PERMANGANATE
Hazard Class: 5.1
UN Number: 1503
Packing Group: II
IMO
Shipping Name: SODIUM PERMANGANATE
Hazard Class: 5.1
UN Number: 1503
Packing Group: II
RID/ADR
Shipping Name: SODIUM PERMANGANATE
Hazard Class: 5.1
UN Number: 1503
Packing group: II
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: O
Risk Phrases:
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 17 Keep away from combustible material.
WGK (Water Danger/Protection)
CAS# 0-00-1: No information available.
CAS# 10101-50-5: No information available.
Canada
CAS# 10101-50-5 is listed on Canadas NDSL List.
CAS# 0-00-1 is not listed on Canadas Ingredient Disclosure List.
CAS# 10101-50-5 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 0-00-1 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 10101-50-5 is listed on the TSCA inventory.
